This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Case Reports

. 2018 Nov-Dec;84(6):758-760.

doi: 10.4103/ijdvl.IJDVL_92_18.

Vismodegib treatment in a HIV positive patient on antiretroviral therapy

Massimiliano Scalvenzi¹, Alessia Villani¹, Caterina Mazzella¹, Milena Cappello¹, Gaia De Fata Salvatores¹, Claudia Costa¹

Affiliations

PMID: 30226476
DOI: 10.4103/ijdvl.IJDVL_92_18

Free article

Case Reports

Vismodegib treatment in a HIV positive patient on antiretroviral therapy

Massimiliano Scalvenzi et al. Indian J Dermatol Venereol Leprol. 2018 Nov-Dec.

Free article

. 2018 Nov-Dec;84(6):758-760.

doi: 10.4103/ijdvl.IJDVL_92_18.

Authors

Massimiliano Scalvenzi¹, Alessia Villani¹, Caterina Mazzella¹, Milena Cappello¹, Gaia De Fata Salvatores¹, Claudia Costa¹

Affiliation

¹ Department of Dermatology, University of Naples Federico II, Naples, Italy.

PMID: 30226476
DOI: 10.4103/ijdvl.IJDVL_92_18

No abstract available

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest

Similar articles

A Novel Alternate Dosing of Vismodegib for Treatment of Patients With Advanced Basal Cell Carcinomas.
Becker LR, Aakhus AE, Reich HC, Lee PK. Becker LR, et al. JAMA Dermatol. 2017 Apr 1;153(4):321-322. doi: 10.1001/jamadermatol.2016.5058. JAMA Dermatol. 2017. PMID: 28114606 No abstract available.
Vismodegib Efficacy in Advanced Basal Cell Carcinoma Maintained with 8-Week Dose Interruptions: A Model-Based Evaluation.
Chanu P, Musib L, Wang X, Cheeti S, Girish S, Bruno R, Lu T, Reddy J, Jin JY, Caro I. Chanu P, et al. J Invest Dermatol. 2021 Apr;141(4):930-933. doi: 10.1016/j.jid.2020.07.036. Epub 2020 Sep 22. J Invest Dermatol. 2021. PMID: 32976880 No abstract available.
PRISModegib: the use of the PRISM test to assess the health-related quality of life of patients with locally advanced basal cell carcinoma undergoing Hedgehog pathway inhibitor therapy.
Gualdi G, Moro R, Regina V, Caravello S, Monari P, Calzavara-Pinton PG. Gualdi G, et al. Br J Dermatol. 2019 Aug;181(2):406-407. doi: 10.1111/bjd.17754. Epub 2019 May 6. Br J Dermatol. 2019. PMID: 30737996 No abstract available.
Managing adverse events associated with vismodegib in the treatment of basal cell carcinoma.
Fife K, Herd R, Lalondrelle S, Plummer R, Strong A, Jones S, Lear JT. Fife K, et al. Future Oncol. 2017 Jan;13(2):175-184. doi: 10.2217/fon-2016-0296. Epub 2016 Sep 19. Future Oncol. 2017. PMID: 27640448 Review.
New perspectives in the management of basal cell carcinoma.
Martín-Gorgojo A, Pastushenko I. Martín-Gorgojo A, et al. Actas Dermosifiliogr. 2014 Nov;105(9):874-5. doi: 10.1016/j.ad.2014.04.007. Epub 2014 Jun 14. Actas Dermosifiliogr. 2014. PMID: 24934656 Review. English, Spanish. No abstract available.

See all similar articles

Cited by

Hair Loss in Patients Treated with Vismodegib: A Single-Center Retrospective Study.
Villani A, Fabbrocini G, Costa C, Scalvenzi M. Villani A, et al. Skin Appendage Disord. 2020 Sep;6(5):280-282. doi: 10.1159/000508825. Epub 2020 Aug 5. Skin Appendage Disord. 2020. PMID: 33088812 Free PMC article.
Low-Dose Vismodegib as Maintenance Therapy After Locally Advanced Basal Cell Carcinoma Complete Remission: High Efficacy with Minimal Toxicity.
Scalvenzi M, Cappello M, Costa C, Fabbrocini G, Luciano M, Villani A. Scalvenzi M, et al. Dermatol Ther (Heidelb). 2020 Jun;10(3):465-468. doi: 10.1007/s13555-020-00371-1. Epub 2020 Apr 2. Dermatol Ther (Heidelb). 2020. PMID: 32240528 Free PMC article.
Management of Advanced Invasive Melanoma: New Strategies.
Villani A, Scalvenzi M, Micali G, Lacarrubba F, Fornaro L, Martora F, Potestio L. Villani A, et al. Adv Ther. 2023 Aug;40(8):3381-3394. doi: 10.1007/s12325-023-02555-5. Epub 2023 Jun 12. Adv Ther. 2023. PMID: 37306810 Free PMC article. Review.
Sonidegib: Safety and Efficacy in Treatment of Advanced Basal Cell Carcinoma.
Villani A, Fabbrocini G, Costa C, Scalvenzi M. Villani A, et al. Dermatol Ther (Heidelb). 2020 Jun;10(3):401-412. doi: 10.1007/s13555-020-00378-8. Epub 2020 Apr 15. Dermatol Ther (Heidelb). 2020. PMID: 32297221 Free PMC article. Review.
Non-Melanoma Skin Cancer in People Living With HIV: From Epidemiology to Clinical Management.
Venanzi Rullo E, Maimone MG, Fiorica F, Ceccarelli M, Guarneri C, Berretta M, Nunnari G. Venanzi Rullo E, et al. Front Oncol. 2021 Aug 4;11:689789. doi: 10.3389/fonc.2021.689789. eCollection 2021. Front Oncol. 2021. PMID: 34422644 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Scientific Scholar
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information